Posted by Michael Wonder on 13 Oct 2022
HARmonized protocol template to enhance reproducibility of hypothesis evaluating real world evidence studies on treatment effects: a good practices report of a joint ISPE/ISPOR Task Force
12 October 2022 - Ambiguity in communication of key study parameters limits the utility of real-world evidence studies in health care decision-making.
The International Society for Pharmacoepidemiology and ISPOR convened a joint task force, including representation from key international stakeholders, to create a harmonised protocol template for real world evidence studies that evaluate a treatment effect and are intended to inform decision-making.
